Publication & Citation Trends
Publications
51 total
Abstract LB422: Selective targeting of CDK2 using molecular glue degraders for the treatment of HR-positive/HER2-negative breast cancer
Cited by 1
Semantic Scholar
Abstract P5-01-26: Selective Targeting of CDK2 Using Molecular Glue Degraders for the Treatment of HR-Positive/HER2-Negative Breast Cancer
Cited by 0
Semantic Scholar
Abstract 3294: The GSPT1 molecular glue degrader MRT-2359 is active against prostate cancer
Cited by 3
Semantic Scholar
Abstract 3449: Development of MRT-2359, an orally bioavailable GSPT1 molecular glue degrader, for the treatment of lung cancers with MYC-induced translational addiction
Cited by 8
Semantic Scholar
Abstract 3929: Identification of MRT-2359 a potent, selective and orally bioavailable GSPT1-directed molecular glue degrader (MGD) for the treatment of cancers with Myc-induced translational addiction
Cited by 16
Semantic Scholar
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling PDF
Cited by 863
OpenAlex
Improving deconvolution methods in biology through open innovation competitions: an application to the connectivity map OA
Cited by 1
Semantic Scholar
Advancing computational biology and bioinformatics research through open innovation competitions OA
Cited by 9
Semantic Scholar
Assessment of network module identification across complex diseases OA
Cited by 261
Semantic Scholar
Research Topics
Bioinformatics and Genomic Networks
(14)
Gene expression and cancer classification
(12)
Computational Drug Discovery Methods
(9)
Animal Vocal Communication and Behavior
(8)
Animal Behavior and Reproduction
(5)
Affiliations
Broad Institute
Boston University
Harvard University
Royal Prince Alfred Hospital
Jnana Therapeutics (United States)